Restless Legs Syndrome: Symptoms, Causes, and Effective Treatments (2026)

Restless Legs Syndrome (RLS) — also called Willis-Ekbom Disease — is one of the most common yet frequently unrecognized sleep disorders, affecting approximately 5–10% of the general population. Despite its prevalence, many sufferers go years without a correct diagnosis, attributing their symptoms to anxiety, growing pains, or circulation problems. Understanding what RLS actually is and what treatments are available can dramatically improve quality of life for people affected by it.

What RLS Actually Feels Like

The defining feature of RLS is an irresistible urge to move the legs, typically accompanied by uncomfortable sensations described variously as: crawling, creeping, pulling, throbbing, aching, itching (inside the leg), electric-like buzzing, or pressure. These sensations are primarily internal (deep within the muscle or bone) rather than surface sensations.

Four diagnostic criteria define RLS:

Urge to move the legs (usually accompanied by uncomfortable sensations)
Begins or worsens with rest or inactivity — sitting or lying down triggers or amplifies symptoms
Partially or totally relieved by movement — walking, stretching, or massaging temporarily alleviates
Worse in the evening or night — peak symptoms typically occur between 9pm–3am, following a circadian pattern

These symptoms must cause significant distress or impairment — not be fully explained by another condition — to qualify as RLS.

Related: Periodic Limb Movement Disorder (PLMD)

Approximately 80% of people with RLS also have Periodic Limb Movement Disorder — repetitive, involuntary movements (typically leg jerks) occurring every 20–40 seconds during sleep. Unlike RLS, PLMD occurs during sleep and the person is usually unaware of it (though a bed partner often isn't). PLMD fragments sleep, producing excessive daytime sleepiness even when total sleep time appears adequate. Bed partners of PLMD patients sometimes describe being kicked repeatedly during the night.

Causes and Risk Factors

Iron Deficiency: The Most Important Modifiable Factor

Iron plays a critical role in dopamine synthesis and transport — and dopamine dysfunction is central to RLS pathophysiology. Iron deficiency (including borderline deficiency that may not produce anemia) is strongly associated with RLS and can independently cause it. Serum ferritin below 50–75 ng/mL (even in the technically "normal" range) is associated with RLS, and iron supplementation corrects RLS in a meaningful proportion of iron-deficient patients. Ferritin testing is a critical first step in RLS evaluation.

Genetics

RLS has a strong familial component — approximately 50% of people with RLS have a first-degree relative with the condition. Multiple genetic variants have been identified that increase susceptibility, with variants in genes related to dopaminergic function and neuronal development being particularly implicated.

Pregnancy

RLS occurs in approximately 20–25% of pregnancies, with peak incidence in the third trimester. Mechanisms include iron deficiency (common in pregnancy), folate deficiency, hormonal changes, and increased blood volume. Pregnancy-associated RLS typically resolves after delivery but may predict future RLS recurrence.

Other Associations

Kidney disease (particularly end-stage renal disease — RLS affects 20–30% of dialysis patients)
Peripheral neuropathy
Parkinson's disease
Medications that can trigger or worsen RLS: antidopaminergic medications (antipsychotics, metoclopramide), antihistamines, antidepressants (particularly SSRIs and TCAs, though not all)
Caffeine and alcohol consumption

Treatment: A Stepped Approach

Step 1: Address Iron Deficiency

Before any pharmacological treatment, serum ferritin should be tested. If below 75 ng/mL, oral iron supplementation (typically ferrous sulfate 325mg three times daily with vitamin C for absorption, on an empty stomach) should be trialed for several months. If oral iron is poorly tolerated or insufficient, intravenous iron may be considered — studies show IV iron can provide dramatic, sustained RLS improvement in iron-deficient patients. Ferritin optimization addresses the underlying mechanism for many patients and may eliminate the need for dopaminergic medications.

Step 2: Lifestyle and Behavioral Approaches

Reduce/eliminate caffeine and alcohol — both worsen RLS symptoms in many people
Regular moderate exercise — lower-to-moderate intensity aerobic exercise improves RLS symptoms; paradoxically, high-intensity exercise can temporarily worsen symptoms
Cognitive strategies during symptom episodes: mental distraction tasks (crossword puzzles, video games, intense cognitive work) can reduce symptom intensity; some patients use temperature strategies (cooling or warming the legs)
Review medications — with physician guidance, identify any medications that may be worsening RLS
Sleep hygiene — consistent sleep schedule, avoiding sleep deprivation (which worsens RLS)

Step 3: Medications

First-line pharmacological treatments:

Alpha-2-delta ligands (gabapentin/Neurontin, pregabalin/Lyrica, gabapentin enacarbil/Horizant): Now considered first-line by most guidelines, particularly for patients with pain, sleep disruption, or anxiety. Reduce symptom severity and improve sleep. Lower augmentation risk than dopamine agonists
Dopamine agonists (pramipexole/Mirapex, ropinirole/Requip, rotigotine patch/Neupro): Highly effective for RLS symptoms but carry a significant long-term risk of augmentation (see below). Used when alpha-2-delta ligands are insufficient or poorly tolerated

Augmentation — a critical concern with dopamine agonists: Augmentation is a paradoxical worsening of RLS that can develop with long-term dopamine agonist use — symptoms spread to the arms, occur earlier in the day, and become more severe. Up to 50% of long-term dopamine agonist users develop augmentation. Recognizing and managing augmentation typically involves switching to non-dopaminergic treatment.

Frequently Asked Questions

Q: How is RLS different from leg cramps at night?

Nocturnal leg cramps (charley horses) are distinct from RLS in several ways: cramps are sudden, intensely painful muscle spasms that involuntarily contract and are painful rather than producing the urge-to-move sensation; cramps are not consistently relieved by movement (moving may actually worsen the cramp initially); cramps don't follow the same circadian evening pattern; and cramps typically resolve quickly with stretching. RLS, by contrast, produces uncomfortable sensations and an irresistible urge to move that is temporarily relieved by movement — not acute severe pain — and follows a consistent evening/nighttime worsening pattern. Both can disrupt sleep but require different management approaches.

Q: Can children have RLS?

Yes — pediatric RLS is significantly underdiagnosed, partly because children describe symptoms differently ("my legs need to move," "bugs crawling," "ouch-ies") and partly because symptoms are often dismissed as growing pains or anxiety. Pediatric RLS can substantially disrupt sleep, contributing to behavioral problems, inattention, and hyperactivity that may be mistaken for or overlap with ADHD. Iron deficiency is particularly common as a cause in children. Any child with significant unexplained nighttime leg discomfort, reluctance to sleep due to leg sensations, or a family history of RLS warrants evaluation by a physician familiar with pediatric sleep disorders.

Q: What immediate techniques help when RLS symptoms strike?

Movement is the most reliable immediate relief — walking, pacing, leg stretches, calf raises, and leg massage all provide temporary symptom reduction. Temperature changes help some people: cool baths or ice packs for some; warm baths or heating pads for others (individual response varies). Intense mental distraction — video games, puzzles, absorbing reading — reduces symptom perception for some people by competing for attention. Progressive muscle relaxation may reduce the intensity of restlessness. For severe nighttime episodes, getting out of bed and moving around (rather than lying trying to will the symptoms away) is more effective and less frustrating than attempting immobile symptom tolerance.

Q: Is RLS a lifelong condition?

For primary (idiopathic) RLS, it tends to be a chronic condition with fluctuating severity — symptoms may improve for periods and worsen during stress, illness, iron deficiency, pregnancy, or with certain medications. It typically worsens gradually over decades in most patients. For secondary RLS (caused by iron deficiency, pregnancy, or medications), treating the underlying cause can produce significant improvement or remission. Effective treatment dramatically improves quality of life even when remission isn't achievable — most patients with appropriately treated RLS achieve good symptom control. Working with a physician experienced in sleep medicine produces better outcomes than empirical self-management for moderate-severe RLS.

Q: What ferritin level should I aim for if I have RLS?

Sleep medicine guidelines generally recommend targeting ferritin above 75 ng/mL (some recommend above 100 ng/mL) in RLS patients — higher than the standard laboratory reference range "normal" lower limit of 12–20 ng/mL. This is because the brain's iron metabolism requires higher serum ferritin levels to maintain adequate central nervous system iron availability. Many RLS patients who are technically "not anemic" and within standard lab reference ranges still show significant RLS improvement with iron supplementation that raises ferritin above 75 ng/mL. Monitoring ferritin response to supplementation every 3 months and continuing supplementation until the target is reached is the appropriate management approach.

References:
1. Allen RP et al. "Restless legs syndrome/Willis-Ekbom disease diagnostic criteria." Sleep Medicine. 2014. sciencedirect.com
2. Silber MH et al. "The Management of Restless Legs Syndrome: An Updated Algorithm." Mayo Clinic Proceedings. 2021.
3. Aurora RN et al. "The treatment of restless legs syndrome and periodic limb movement disorder in adults." Sleep. 2012.
4. Earley CJ et al. "Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome." Neurology. 2000.